Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England

Author:

Requena GemaORCID,Banks VictoriaORCID,Czira Alexandrosz,Wood RobertORCID,Tritton Theo,Wild RosieORCID,Compton Chris,Duarte Maria,Ismaila Afisi SORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference34 articles.

1. What is early COPD and why is it important?

2. Pathophysiology of the Small Airways in Chronic Obstructive Pulmonary Disease

3. G. B. D. Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3

4. British Lung Foundation. Chronic obstructive pulmonary disease (COPD) statistics; 2021. Available from: https://statistics.blf.org.uk/copd. Accessed October 2021.

5. Health and Safety Executive. Work-related chronic obstructive pulmonary disease (COPD) statistics in Great Britain; 2020. Available from: https://www.hse.gov.uk/statistics/causdis/copd.pdf. Accessed October 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3